Lv51
1580 积分 2023-05-20 加入
Safely lowering triglycerides through ANGPTL4 inhibition
10天前
已完结
Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover
23天前
已完结
Challenges in mitigating weight regain with incretin-based therapy
1个月前
已关闭
Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial
1个月前
已完结
Visceral adiposity index as a predictor of type 2 diabetes mellitus risk: A systematic review and dose–response meta-analysis
1个月前
已完结
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
3个月前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
3个月前
已完结
The story of amylin: from physiology to therapy
4个月前
已完结
Dynamics of fat cell turnover in humans
5个月前
已完结
Dynamics of fat cell turnover in humans
5个月前
已完结
皖公网安备34019202002308
